We want to welcome Dr. Enquan Xu to the Gutmann Laboratory. Dr. Xu graduated from University of Nebraska Medical Center in 2017 with a PhD in Neuropharmacology and Immunology. He previously studied the role of immune cells in methamphetamine-induced Parkinson’s disease. Currently, he serves as a staff scientist in the Gutmann Laboratory. Enquan is focused on developing next-generation models of NF1 brain tumors.
The Gutmann Laboratory Welcomes New Staff Scientist, Dr. Enquan Xu
